Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine

The efficacy of trastuzumab emtansine (T-DM1) is prolonged for some patients; however, the predictive factors remain unknown. We focused on a peripheral blood biomarker, the neutrophil-to-lymphocyte ratio (NLR), regarding T-DM1 treatment efficacy. Fifty-three advanced or metastatic breast cancers tr...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Imamura, Michiko, Morimoto, Takashi, Egawa, Chiyomi, Fukui, Reiko, Bun, Ayako, Ozawa, Hiromi, Miyagawa, Yoshimasa, Fujimoto, Yukie, Higuchi, Tomoko, Miyoshi, Yasuo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2019
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6372578/
https://ncbi.nlm.nih.gov/pubmed/30755651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-37633-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia